Views & Analysis Regulatory timelines in the Asia-Pacific Snapshot of clinical trial application processes in the region.
News IBM Watson to help personalise cancer care in China Watson for Oncology will be deployed across 21 Chinese hospitals to aid in care decisions.
Views & Analysis Trends in clinical research in China A large patient pool plus growing market opportunities are making China increasingly attractive for clinical trials.
News BeyondSpring looks to tap China for lung cancer drug develop... Company's alliance in huge lung cancer market could pay off
News China to begin first in-human CRISPR trial next month Phase 1 trial will investigate safety and tolerability in non-small cell lung cancer.
News MSD stops trials of BTK inhibitor for blood cancers MSD has stopped development of BTK inhibitor nemtabrutinib, acquired via its $2.7bn takeover of ArQule, after trial results pointed to a safety issue.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.